NCT00739596 - Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans | Biotech Hunter

Enrollment

332

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren Hydrochlorothiazide (HCTZ): 8 weeks

Aliskiren HCTZ (150/12.5 mg) for 1 week followed by forced titration to Aliskiren HCTZ (300/25 mg) for remaining 7 weeks

DRUG

Amlodipine: 8 weeks

Amlodipine 5 mg for 1 week followed by forced titration to Amlodipine 10 mg for remaining 7 weeks

Trial Locations (1)

Sites in USA, East Hanover